Status:
COMPLETED
Sodium Watchers Program - Hypertension
Lead Sponsor:
Misook L. Chung
Conditions:
Hypertension
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Hypertensive adults are a vulnerable population at high risk of developing cardiovascular disease. Despite the many interventions tested to reduce hypertension, it remains a major risk factor that is ...
Detailed Description
Hypertension or high blood pressure is known as a silent killer because it can exist for decades without producing symptoms while leading to chronic cardiovascular disease and stroke. The long-term ob...
Eligibility Criteria
Inclusion
- Systolic Blood Pressure equal to or greater than 140 mmHG and diastolic pressure equal to and greater than 90 mmHG
- Are Able to speak and write English
- Are over 40 years of age
Exclusion
- Hypertension below the age of 40
- Major Clinical cognitive impairment
- Have major co-morbidities or co-existing terminal illnes
- Have a dietary prescription that prevents following a 2-3 gram sodium diet
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2021
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04076280
Start Date
September 1 2019
End Date
August 19 2021
Last Update
December 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40506